Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections.
about
Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiologyConverting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into playRespiratory syncytial virus infections in infants affected by primary immunodeficiency.Differential impact of respiratory syncytial virus and parainfluenza virus on the frequency of acute otitis media is explained by lower adaptive and innate immune responses in otitis-prone children.Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.Vaccination against RSV: is maternal vaccination a good alternative to other approaches?Respiratory syncytial virus infection and immunity.Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.Actin- and clathrin-dependent mechanisms regulate interferon gamma release after stimulation of human immune cells with respiratory syncytial virus.Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse.Functions of Antibodies.Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice.Progress in respiratory virus vaccine development
P2860
Q21133803-FCBF38D1-53F3-4066-A340-B331C16769B1Q27468870-AE439758-C907-4B84-9AB3-52983F219F5EQ33892605-FEE266A3-33F4-4B48-8A97-B052FB3BB2E3Q34137781-3AC391DB-28BD-4D13-8A13-3F0735352FA6Q36363236-424EDC12-B09C-4852-A495-5C11807AC5ECQ36978676-B3A43CAD-6454-43CE-BB22-028F813AB343Q37514757-296094B6-7F6B-481A-8F0D-9AB98942F10DQ37980056-570F60EE-0F48-4C69-A084-9E1D7131E1FEQ38162418-EA4E84BE-0388-422C-BE4F-F1110189BCEDQ39027049-DB9F8AD2-8E9B-4F12-B845-AF20E52E019BQ39333361-F9100DA2-95B3-424A-B6A7-846A83471FF1Q40959795-93143F09-61C3-4F78-BFD0-3A44E36CC655Q41032140-D712C35F-FB82-4B61-A519-46F260D8F00EQ41741684-9D2F5706-B2F3-45CE-BBCF-4CF2B2824B09Q41843303-E2F2D5C5-5861-4DF7-A75F-FA37A57B613FQ56894869-70E07801-7930-4CDD-BD66-86EA7C98A6AD
P2860
Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Serum antibodies critically af ...... ry syncytial virus infections.
@en
Serum antibodies critically af ...... ry syncytial virus infections.
@nl
type
label
Serum antibodies critically af ...... ry syncytial virus infections.
@en
Serum antibodies critically af ...... ry syncytial virus infections.
@nl
prefLabel
Serum antibodies critically af ...... ry syncytial virus infections.
@en
Serum antibodies critically af ...... ry syncytial virus infections.
@nl
P2093
P356
P1476
Serum antibodies critically af ...... ory syncytial virus infections
@en
P2093
Debby Kruijsen
Frank E Coenjaerts
Grada M van Bleek
Jan L Kimpen
Marco C Viveen
Mark J Bakkers
Nathalie O van Uden
P304
P356
10.4049/JIMMUNOL.1002645
P407
P577
2010-10-22T00:00:00Z